Status:
RECRUITING
Unveiling Physiological and Psychosocial Pain Components with an Artificial Intelligence Based Telemonitoring Tool
Lead Sponsor:
ETH Zurich
Collaborating Sponsors:
Balgrist University Hospital
Conditions:
Nociceptive Pain
Neuropathic Pain
Eligibility:
All Genders
18-80 years
Brief Summary
The pAIn-sense study aims to revolutionize the monitoring and treatment of chronic pain, a major health concern that significantly impacts psychological well-being and quality of life. Traditional app...
Detailed Description
Chronic pain has long been known as one of the major health concerns, impacting psychological health, functioning, and quality of life. However, its treatment is complex and is challenged by a complex...
Eligibility Criteria
Inclusion
- Ongoing nociceptive pain after an injury or Neuropathic pain (acute or chronic)
- Familiar with using electronic devices
Exclusion
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
- Unable or not willing to give informed consent
Key Trial Info
Start Date :
September 29 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2028
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT06044584
Start Date
September 29 2023
End Date
December 31 2028
Last Update
January 20 2025
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Unita Spinale ASL
Pietra Ligure, Savona, Italy, 17027
2
Neuroengineering Lab
Zurich, Canton of Zurich, Switzerland, 8001
3
Balgrist University Hospital
Zurich, Canton of Zurich, Switzerland, 8008
4
CRR Suva (Clinique romande de réadaptation)
Sion, Valais, Switzerland, 1950